Stem cell exosome high-activity freeze-drying formula and freeze-drying process thereof
By adding sodium alginate, sericin mixture, mannitol and buckwheat extract to the stem cell exosome lyophilized formula, and using prefreeze treatment and vacuum freeze-drying technology, the low exosome resuscitation rate in the existing technology was solved. Problem, the biological activity and stability of the lyophilized formula has been significantly improved and is suitable for a variety of medical applications.
Patent Information
- Application Number
- CN202411187981.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The exosome resuscitation rate of existing stem cell exosome lyophilized formulas is low, resulting in a decrease in biological activity and affecting tissue repair and therapeutic effects.
Using a high-active lyophilization formula for stem cell exosomes, including stem cell exosomes, sodium alginate, sericin mixture, mannitol, buckwheat extract and beta-mercaptoethanol, through specific lyophilization processes and treatment steps, including pre- Freeze treatment and vacuum freeze-drying to protect exosome structure and biological activity.
It significantly improves the resuscitation rate and biological stability of stem cell exosome lyophilized formula, maintains the high activity of exosomes, and is suitable for regenerative medicine, disease diagnosis and treatment and other fields.
